Public Employees Retirement System of Ohio Acquires 88,205 Shares of Avantor, Inc. (NYSE:AVTR)

Public Employees Retirement System of Ohio boosted its stake in shares of Avantor, Inc. (NYSE:AVTR) by 34.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 346,822 shares of the company’s stock after purchasing an additional 88,205 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in Avantor were worth $8,972,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Cetera Advisors LLC bought a new position in shares of Avantor during the first quarter worth approximately $249,000. SG Americas Securities LLC increased its position in Avantor by 222.0% during the 2nd quarter. SG Americas Securities LLC now owns 19,996 shares of the company’s stock worth $424,000 after buying an additional 13,786 shares during the period. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Avantor by 2.8% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company’s stock worth $571,000 after buying an additional 733 shares in the last quarter. ORG Partners LLC lifted its holdings in shares of Avantor by 5,773.0% during the second quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock worth $122,000 after buying an additional 5,773 shares in the last quarter. Finally, Swedbank AB boosted its position in shares of Avantor by 1.3% in the second quarter. Swedbank AB now owns 107,182 shares of the company’s stock valued at $2,272,000 after acquiring an additional 1,327 shares during the period. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have weighed in on AVTR shares. Wells Fargo & Company dropped their price objective on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. Barclays dropped their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. Royal Bank of Canada reissued an “outperform” rating and set a $34.00 price target on shares of Avantor in a research report on Thursday, September 26th. UBS Group dropped their price objective on Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday, October 8th. Finally, Robert W. Baird reduced their target price on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. Three analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $27.69.

Avantor Stock Down 0.6 %

AVTR stock opened at $22.53 on Friday. The firm has a 50-day moving average price of $22.59 and a 200-day moving average price of $23.55. Avantor, Inc. has a 12 month low of $19.59 and a 12 month high of $28.00. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The stock has a market capitalization of $15.33 billion, a P/E ratio of 48.98, a price-to-earnings-growth ratio of 2.59 and a beta of 1.29.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.